A groundbreaking Nature study reports researchers have used CRISPR gene editing technology to correct a mutation that causes hypertrophic cardiomyopathy in embryos. The technique also prevents the mutation from passing to future generations.
With the aid of CRISPR gene editing techniques, researchers have identified a new biomarker for Alzheimer's disease. The study reports a deficiency of the protein STIM1 could be implicated in the sporadic version of the neurodegenerative disease.
A new study sheds light on the mechanisms of gyrus formation.
A new study confirms a mutation caused dysfunction associated with Alzheimer's and proposes a new therapeutic target.
Researchers use CRISPR to modulate genes in order to reduce tissue damage and inflammation for people with neck and back pain.
Using CRISPR-Cas9 gene editing, researchers identified actionable pathways responsible for the growth of glioblastoma stem cells. By reverse engineering brain cancer cells, multiple potential new targets for cancer treatments have been uncovered.
Using CRISPR gene editing, researchers introduce the SHANK3 gene variant into macaque monkeys. SHANK3 has previously been linked to autism in humans. The monkeys with the SHANK3 mutations exhibited behavioral traits and brain activity patterns similar to those seen in humans on the autism spectrum, Researchers hope the new model will facilitate new avenues of research for ASD.